Equanimity AI

AI-driven Platform for Personalized Chronic Pain Assessment

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in July 2022 by Erez Levanon and Samuel Hazak, Equanimity AI operates with 1–10 employees. The company is currently in its Pre-Funding stage, developing an AI-driven platform for chronic pain assessment.

Business overview

Equanimity AI is a digital health startup focused on transforming chronic pain management through artificial intelligence and wearable technology. The company's core technology integrates data from wearables, smartphones, and patient-reported outcomes to create an objective pain map and an Equanimity Pain Score, providing clinicians with a quantifiable measure of pain intensity. This B2B SaaS solution is designed to integrate with existing clinical workflows, targeting interventional pain clinics and healthcare providers in the United States, with potential expansion into the B2B2C market.

Company Intelligence Q&A

What is Equanimity AI's primary focus?
Equanimity AI focuses on transforming chronic pain management through an AI-driven platform that utilizes wearable technology and data integration for objective pain assessment.
When was Equanimity AI founded?
Equanimity AI was founded in July 2022 by Erez Levanon and Samuel Hazak.
What technology does Equanimity AI leverage?
Equanimity AI leverages artificial intelligence, machine learning, deep learning, and natural language processing to analyze multimodal data for chronic pain assessment.
Which markets does Equanimity AI target?
Equanimity AI primarily targets the United States market, focusing on interventional pain clinics and healthcare providers.
What is the business model of Equanimity AI?
Equanimity AI operates on a B2B SaaS model, providing its platform to healthcare providers, with potential future expansion into a B2B2C model for patient subscriptions.